Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Claris Lifesciences Ltd Receives ANDA Approval For Metroprolol Tartrate Injection In United States


Wednesday, 1 May 2013 10:55pm EDT 

Claris Lifesciences Ltd announced that it has received ANDA approval for Metroprolol Tartrate Injection in the United States of America (US). Metoprolol Tratrate injection is used to treat angina (chest pain) and hypertension (high blood pressure). It is also used to treat or prevent heart attack. 

Company Quote

158.95
-1.3 -0.81%
5:59am EDT